T1	Participants 105 209	Nutritional Prevention of Cancer Trial was a double-blind, randomized, placebo-controlled clinical trial
T2	Participants 326 370	1312 patients from the Eastern United States
T3	Participants 823 892	within subgroups, defined by baseline characteristics, was evaluated.
T4	Participants 1389 1495	Nutritional Prevention of Cancer Trial conducted among individuals at high risk of nonmelanoma skin cancer
